Edaravone for acute ischaemic stroke

scientific article (publication date: 7 December 2011)

Edaravone for acute ischaemic stroke is …
instance of (P31):
meta-analysisQ815382
scholarly articleQ13442814

External links are
P356DOI10.1002/14651858.CD007230.PUB2
P8608Fatcat IDrelease_2pcd5ddgvbe7fanlz376z2wzpi
P698PubMed publication ID22161410

P2093author name stringBo Wu
Ming Liu
Juntao Li
Shihong Zhang
Qingwei Yang
Weizheng Li
Shejun Feng
Wenming Yuan
P2860cites workAntiplatelet therapy for acute ischaemic strokeQ24242725
Thrombolysis for acute ischaemic strokeQ24247962
Bias in meta-analysis detected by a simple, graphical testQ24685585
Measuring inconsistency in meta-analysesQ27860655
Do certain countries produce only positive results? A systematic review of controlled trialsQ33685036
Use of the Barthel index and modified Rankin scale in acute stroke trials.Q33870093
A critical assessment of edaravone acute ischemic stroke efficacy trials: is edaravone an effective neuroprotective therapy?Q33938450
Free radical trapping as a therapeutic approach to neuroprotection in stroke: experimental and clinical studies with NXY-059 and free radical scavengersQ34414245
Heart disease and stroke statistics--2007 update: a report from the American Heart Association Statistics Committee and Stroke Statistics SubcommitteeQ34595917
Stroke in China: epidemiology, prevention, and management strategiesQ36791760
Strong attenuation of ischemic and postischemic brain edema in rats by a novel free radical scavengerQ41968726
Effect of a novel free radical scavenger, edaravone (MCI-186), on acute brain infarction. Randomized, placebo-controlled, double-blind study at multicentersQ44418044
Effect of MCI-186 on brain edema in ratsQ44710629
Effect of MCI-186 on ischemia-induced changes in monoamine metabolism in rat brainQ46471192
Delayed neuronal death prevented by inhibition of increased hydroxyl radical formation in a transient cerebral ischemiaQ48658567
Antioxidant activity of 3-methyl-1-phenyl-2-pyrazolin-5-oneQ87878260
P921main subjectedaravoneQ335099
P577publication date2011-12-07
P1433published inCochrane Database of Systematic ReviewsQ15750361
P1476titleEdaravone for acute ischaemic stroke

Reverse relations

cites work (P2860)
Q37449324A Novel Therapeutic Peptide as a Partial Agonist of RANKL in Ischemic Stroke
Q33863549Blood Pressure and Penumbral Sustenance in Stroke from Large Vessel Occlusion.
Q37195211Catalpol Induces Neuroprotection and Prevents Memory Dysfunction through the Cholinergic System and BDNF.
Q24187130Cerebrolysin for acute ischaemic stroke
Q56385906Cerebrolysin for acute ischaemic stroke
Q30240224Cerebrolysin for acute ischaemic stroke.
Q35549137Edaravone alleviates Alzheimer's disease-type pathologies and cognitive deficits
Q89490292Edaravone and cyclosporine A as neuroprotective agents for acute ischemic stroke
Q24202093Edaravone for traumatic brain injury
Q35617219Edaravone mitigates hexavalent chromium-induced oxidative stress and depletion of antioxidant enzymes while estrogen restores antioxidant enzymes in the rat ovary in F1 offspring
Q35097388Efficacy and safety of therapies for acute ischemic stroke in China: a network meta-analysis of 13289 patients from 145 randomized controlled trials
Q36072867Endothelial cells and astrocytes: a concerto en duo in ischemic pathophysiology
Q98226249Ferroptosis in Acute Central Nervous System Injuries: The Future Direction?
Q38268870Intramyocardial haemorrhage after acute myocardial infarction
Q36476092Macrophages mediate colon carcinoma cell adhesion in the rat liver after exposure to lipopolysaccharide
Q38175890Malignant cerebral edema after large anterior circulation infarction: a review
Q38834682Neuroprotection in acute stroke: targeting excitotoxicity, oxidative and nitrosative stress, and inflammation
Q28079392Nonsurgical therapy for hydrocephalus: a comprehensive and critical review
Q26995219Oxidative stress, DNA damage, and the telomeric complex as therapeutic targets in acute neurodegeneration
Q90168301Oxidative stress-responsive apoptosis inducing protein (ORAIP) plays a critical role in cerebral ischemia/reperfusion injury
Q36650163Phase I clinical study of edaravone in healthy Chinese volunteers: safety and pharmacokinetics of single or multiple intravenous infusions
Q28391569Regulation of signal transduction by reactive oxygen species in the cardiovascular system
Q48342501Safety and efficacy of NA-1 in patients with iatrogenic stroke after endovascular aneurysm repair (ENACT): a phase 2, randomised, double-blind, placebo-controlled trial.
Q55088026Study of respiratory chain dysfunction in heart disease.
Q38336892Taming glutamate excitotoxicity: strategic pathway modulation for neuroprotection
Q38030379Targeting reactive nitrogen species: a promising therapeutic strategy for cerebral ischemia-reperfusion injury
Q40056448Thrombolysis with Low-Dose Tissue Plasminogen Activator 3-4.5 h After Acute Ischemic Stroke in Five Hospital Groups in Japan
Q34095790Total flavonoid of Litsea coreana leve exerts anti-oxidative effects and alleviates focal cerebral ischemia/reperfusion injury
Q38268315Treatment of malignant brain edema and increased intracranial pressure after stroke

Search more.